FDA (Drugs) recall action 83908
The FDA (Drugs) publishes a recall like this one as 18 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 18 pages.
CGMP Deviations: Presence of NDMA impurity detected in product.
The agency’s own wording, quoted from the enforcement report.
Dr. Reddy's is recalling Ranitidine Hydrochloride capsules because of CGMP deviations and the presence of NDMA impurity.
Dr. Reddy's Laboratories is recalling Ranitidine Tablets 75 mg because of the presence of the NDMA impurity.
Dr. Reddy's Laboratories is recalling Ranitidine Tablets 150 mg because of the presence of NDMA impurity. The product was distributed to major distributors throughout the United States.
Dr. Reddy's Laboratories is recalling Ranitidine Tablets 75 mg because the presence of the NDMA impurity was detected in the product.
Dr. Reddy's Laboratories is recalling specific bottles of Ranitidine Tablets 150 mg because an NDMA impurity was detected.
Dr. Reddy's is recalling Ranitidine Hydrochloride capsules because of the presence of the NDMA impurity.
Dr. Reddy's Laboratories is recalling CVS brand Ranitidine Tablets 75 mg because of the presence of NDMA impurity.
Dr. Reddy's is recalling Ranitidine Tablets 75 mg because the FDA detected the NDMA impurity in the product.
Dr. Reddy's Laboratories is recalling Walmart-branded Ranitidine Tablets 150 mg because of the presence of the NDMA impurity.
Dr. Reddy's is recalling Ranitidine Tablets because an NDMA impurity was detected. Consumers should stop using the product and return it to the pharmacy.
Dr. Reddy's Laboratories is recalling Ranitidine Tablets 150 mg because of the presence of NDMA impurity. The product was distributed to major distributors throughout the United States.
Dr. Reddy's Laboratories is recalling Ranitidine Tablets 150 mg because the presence of the NDMA impurity was detected in the product.
Dr. Reddy's Laboratories is recalling Ranitidine Tablets 150 mg because the presence of the NDMA impurity was detected in the product.
Dr. Reddy's Laboratories is recalling Ranitidine Tablets 150 mg because an NDMA impurity was detected. The product was distributed to major distributors throughout the United States.
Dr. Reddy's Laboratories is recalling Ranitidine Tablets 150 mg because of the presence of the NDMA impurity.
Dr. Reddy's Laboratories is recalling Ranitidine Tablets 75 mg because of the presence of NDMA impurity. The product was distributed to major distributors throughout the United States.
Dr. Reddy's Laboratories is recalling Ranitidine Tablets 150 mg because of the presence of the NDMA impurity.
Dr. Reddy's Laboratories is recalling Ranitidine Tablets 75 mg because of the presence of the NDMA impurity.